Elipse, the first procedureless gastric balloon for weight loss: a prospective, observational, open-label, multicenter study
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
Background and study aims Conventional gastric balloons for weight loss require endoscopy for placement and removal. The Elipse device is swallowed, resides in the stomach for 4 months, and is then expelled. The objectives of this study were to assess the safety of Elipse and to measure its effects on weight loss, metabolic parameters, and quality of life. Methods Each participant swallowed one Elipse device, which was filled with 550 mL of filling fluid through a thin delivery catheter that was then removed. Weight was measured every 2 weeks, and metabolic parameters and quality of life were assessed at baseline and at trial exit. Results 34 patients, with a mean body mass index of 34.8 kg/m 2 , were enrolled. All 34 patients successfully swallowed the Elipse device. All adverse events were either self-limiting or resolved with medication. All balloons were safely excreted. At 4 months, the mean percent total body weight loss was 10 %. Mean waist circumference was reduced by 8.4 cm. Improvements were also seen in hemoglobin A1c, triglycerides, low density lipoprotein, and blood pressure. At trial exit, quality of life measures had improved across all domains. Conclusion These results demonstrate clinically significant weight loss with the Elipse, the first procedureless gastric balloon. The weight loss was similar to that seen in previous studies of endoscopically placed balloons. In addition, Elipse therapy led to improvements in waist circumference, several metabolic parameters, and overall quality of life. ClinicalTrials.gov identifier: NCT 02802007.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bioenterics intragastric balloon: the Italian experience with 2,515 patients
Genco, A., Bruni, T., Doldi, S. B., Forestieri, P., Marino, M., Busetto, L., Giardiello, C., Angrisani, L., Pecchioli, L., Stornelli, P., et al. (2005) · Obesity Surgery · doi:10.1381/0960892055002202 · Cited by 361 · cited 1×
“In contrast, gastric obstruction is a known complication of other gastric balloons that may require early balloon removal [3, 19].”
BackgroundPonce, J., Woodman, G., Swain, J., Wilson, E., English, W., Ikramuddin, S., Bour, E., Edmundowicz, S., Snyder, B., Soto, F., et al. (2015) · Surgery for Obesity and Related Diseases · doi:10.1016/j.soard.2014.12.006 · Cited by 279 · cited 3×
“In particular, endoscopic removal of balloons has previously been associated with aspiration pneumonitis, esophageal perforation, esophageal mucosal tear, and esophageal bleeding [6].”
Background
Cited by
IFSO Worldwide Survey 2016: Primary, Endoluminal, and Revisional Procedures
Angrisani, L., Santonicola, A., Iovino, P., Vitiello, A., Higa, K., Himpens, J., Buchwald, H., & Scopinaro, N. (2018) · Obesity Surgery · doi:10.1007/s11695-018-3450-2 · Cited by 1,032
Endoscopic intragastric balloon: a gimmick or a viable option for obesity?
Claudia Gollisch, K. S., & Raddatz, D. (2020) · Annals of Translational Medicine · doi:10.21037/atm.2019.09.67 · Cited by 37
Various Intragastric Balloons Under Clinical Investigation
Choi, S. J., & Choi, H. S. (2018) · Clinical Endoscopy · doi:10.5946/ce.2018.140 · Cited by 28
Endoscopic bariatrics: current therapies and future directions
Reja, D., Zhang, C., & Sarkar, A. (2022) · Translational Gastroenterology and Hepatology · doi:10.21037/tgh.2020.03.09 · Cited by 24
“The EBT are separated into gastric interventions and small bowel interventions (3,7-14).”
Background
Metadata
- Authors
- Machytka, E., Gaur, S., Chuttani, R., Bojkova, M., Kupka, T., Buzga, M., Giannakou, A., Ioannis, K., Mathus-Vliegen, E., Levy, S., & Raftopoulos, I.
- Venue
- Endoscopy
- Publisher
- Georg Thieme Verlag KG
- Published
- 2016-12-12
- Volume
- 49
- Issue
- 02
- Pages
- 154-160
- ISSN
- 0013-726X (ISSN-L)
- 1438-8812
- OpenAlex
- W2564422167
- Cited by
- 65
- References
- 2
- FWCI
- 8.96
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Elipse, the first procedureless gastric balloon for weight loss: a prospective, observational, open-label, multicenter study. https://app.cochat.ai/papers/10.1055/s-0042-119296
- The paper
- Machytka, E., Gaur, S., Chuttani, R., Bojkova, M., Kupka, T., Buzga, M., Giannakou, A., Ioannis, K., Mathus-Vliegen, E., Levy, S., & Raftopoulos, I. (2016). Elipse, the first procedureless gastric balloon for weight loss: a prospective, observational, open-label, multicenter study. Endoscopy. https://doi.org/10.1055/s-0042-119296
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.